Pharsight

Natroba patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5496931 PARAPRO LLC Insecticide and miticide A83543 compounds and their method of production by fermentation
Mar, 2013

(11 years ago)

US6063771 PARAPRO LLC Formulations for controlling human lice
Jun, 2019

(4 years ago)

US6342482 PARAPRO LLC Formulations for controlling human lice
Jun, 2019

(4 years ago)

US7030095 PARAPRO LLC Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
Jul, 2021

(2 years ago)

US9895388 PARAPRO LLC Methods and compositions useful for controlling cutaneous mites
Nov, 2033

(9 years from now)

Natroba is owned by Parapro Llc.

Natroba contains Spinosad.

Natroba has a total of 5 drug patents out of which 4 drug patents have expired.

Expired drug patents of Natroba are:

  • US5496931
  • US6063771
  • US6342482
  • US7030095

Natroba was authorised for market use on 18 January, 2011.

Natroba is available in suspension;topical dosage forms.

Natroba can be used as the product composition (natroba) is for the topical treatment of human scabies mite infestations by melting and delivering the active ingredient, spinosad, to the stratum corneum where scabies mites live and breed, topical treatment of head lice infestation in patients four (4) years of age and older.

Drug patent challenges can be filed against Natroba from 18 January, 2015.

The generics of Natroba are possible to be released after 25 November, 2033.

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-858) Apr 28, 2024
M(M-152) Nov 30, 2017
New Chemical Entity Exclusivity(NCE) Jan 18, 2016

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using SPINOSAD ingredient

NCE-1 date: 18 January, 2015

Market Authorisation Date: 18 January, 2011

Treatment: Topical treatment of head lice infestation in patients four (4) years of age and older; The product composition (natroba) is for the topical treatment of human scabies mite infestations by melting and...

Dosage: SUSPENSION;TOPICAL

More Information on Dosage

NATROBA family patents

Family Patents